Functional aspects of red cell antigens

Blood Reviews

Volumn 13, Issue 1, 1999, Pages 14-35

  Daniels, G ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ANTIPORTER; CELL PROTEIN; CHEMOKINE RECEPTOR; ERYTHROCYTE ANTIGEN; GLYCOPHORIN C; GLYCOPROTEIN; IMMUNOGLOBULIN RECEPTOR; RHESUS ANTIGEN;

ANION EXCHANGE; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP KIDD SYSTEM; BLOOD GROUP LUTHERAN SYSTEM; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; GENETIC POLYMORPHISM; HUMAN; MEROZOITE; PHENOTYPE; PLASMODIUM VIVAX; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032895115     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(99)90020-6     Document Type: Article

References (188)

1. Daniels G. Human blood groups. Oxford: Blackwell, 1995.
2. Issitt PD, Anstee DJ. Applied blood group serology. 4th edn. Durham, NC: Montgomery Scientific Publications, 1998.
3. Tanner MJA. Molecular and cellular biology of the erythrocyte anion exchanger (AE1). Semin Hemat 1993; 30: 34-57.
4. Tanner MJA. The structure and function of band 3 (AE1): recent developments (review). Mol Mem Biol 1997; 14: 155-165.
5. Bruce LJ, Tanner MJA. Structure-function relationships of band 3 variants. Cell Mol Biol 1996; 42: 953-973.
6. Wainwright SD, Tanner MJA, Martin GEM, Yendle JE, Holmes C. Monoclonal antibodies to the membrane domain of the human crythrocyte anion transport protein. Localization of the C-terminus of the protein to the cyloplasmic side of the red cell membrane and distribution of the protein in some human tissues. Biochem J 1989; 258: 211-220.
7. Nigg EA, Bron C, Giradet M, Cherry RJ. Band 3-glycophorin A association in erythrocyte membranes demonstrated by combining protein diffusion measurements with antibody-induced cross-linking. Biochemistry 1980; 19: 1887 1893.
8. Che A, Cherry RJ. Loss of rotational mobility of band 3 proteins in human erythrocyte membranes induced by antibodies to glycophorin A. Biophys J 1995; 68: 1881 1887.
9. Groves JD, Tanner MJA. Glycophorin A facilitates the expression of human band 3-mediated anion transport in Xenopus oocytes. J Biol Chem 1992; 267: 22163-22170.
10. Hassoun H, Hanada T, Lutchman M et al. Complete deficiency of glycophorin A in red blood cells from mice with targeted inactivation of the band 3 (AE1) gene. Blood 1998; 91: 2146-2151.
11. Southcott MJG, Tanner MJA, Anstee DJ. The expression of human blood group antigens during erythropoicsis in a cell culture system. Blood 1999; in press.
12. Gahmberg CG, Andersson LC. K562-a human leukemia cell line with erythroid features. Semin Hemat 1981; 18: 72-77.
13. Beckman R, Smythe JS, Anstee DJ, Tanner MJA. Functional cell surface expression of band 3 (AE1), in K562 erythroleukemia cells band 3 enhances the cell surface expression of Rh antigens. Transfusion Med 1998; 8 supplement 1: in press (abstract).
14. Zelinski T. Erythrocyte band 3 antigens and the Diego blood group system. Blood 1998; 92: 4428-4438.
15. a) blood group antigen. Biochem J 1992; 288: 713-716.
16. a) blood group antigen are associated with the human erythrocyte band 3 mutation Pro854→Leu. J Biol Chem 1994; 269: 16155-16158.
17. Salhany JM, Sloan RL, Schopfer LM. Characterization of the stilbenedisulphonate binding site on band 3 Memphis variant II (Pro-854→Leu). Biochem J 1996; 317: 509-514.
18. Bruce LJ, Ring SM, Anstee DJ, Reid ME, Wilkinson S, Tanner MJA. Changes in the blood group Wright antigens are associated with a mutation at amino acid 658 in human erythrocyte band 3: a site of interaction between band 3 and glycophorin A under certain conditions. Blood 1995; 85: 541-547.
19. Huang C-H, Reid ME, Xie S-S, Blumenfeld OO. Human red blood cell Wright antigens: a genetic and evolutionary perspective on glycophorin A-band 3 interaction. Blood 1996; 87: 3942-3947.
20. Jarolim P, Moulds JM, Moulds JJ, Rubin HL, Dahr W. MARS and AVIS blood group antigens: polymorphism of glycophorin A affects band 3 glycophorin a interaction. Blood 1996: 88 supplement 1: 182a (abstract).
21. b expression. Transfusion 1995; 35 supplement: 40S (abstract).
22. Wang L, Groves JD, Mawby WJ, Tanner MJA. Complementation studies with co-expressed fragments of the human red cell anion transporter (band 3; AE1). The role of some exofacial loops in anion transport. J Biol Chem. 1997; 272: 10631-10638.
23. Jarolim P, Palek P, Amato D et al. Deletion in erythrocyte band 3 gene in malaria resistant Southeast Asian ovalocytosis. Proc Natl Acad Sci USA 1991; 88: 11022 11026.
24. Tanner MJA, Bruce L, Martin PG, Rearden DM, Jones GL. Melanesien hereditary ovalocytes have a deletion in red cell band 3. Blood 1991; 78: 2785-2786.
25. Scholield AE, Reardon DM, Tanner MJA. Defective anion transport activity of the abnormal band 3 in hereditary ovalocytic blood cells. Nature 1992; 355: 836-838.
26. Liu S-C, Jarolim P, Rubin HL, Palek J. The homozygous state for the band 3 protein mutation in Southeast Asian ovalocytosis may be lethal. Blood 1994; 84: 3590-3591.
27. Ribeiro ML, Alloisio N, Almeida H et al. Hereditary spherocytosis with total absence of band 3 in a baby with mutation Coimbra (V488M) in the homozygous state. Blood 1997; 90 supplement 1: 265a (abstract).
28. Peters LL, Shivdasani RA, Lui SC et al. Anion exchanger 1 (band 3) is required to prevent crythrocyte membrane surface loss but not to form the membrane skeleton. Cell 1996; 86: 917-927.
29. Southgate CD, Chisti AH, Mitchell B, Yi SJ, Palek J. Targeted disruption of the murine erythroid band 3 gene results in spherocytosis and severe haemolytic anaemia despite a normal membrane skeleton. Nat Genet 1996; 14: 227-230.
30. Inaba M, Yawata A, Koshino I et al. Defective anion transport and marked spherocytosis and membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation. J Clin Invest 1996; 97: 1804-1817.
31. Jarolim P, Murray JL, Rubin HL et al. Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency. Blood 1996; 88: 4366-4374.
32. Booth PB, Serjeantson S, Woodfield DG, Amato D. Selective depression of blood group antigens associated with hereditary ovalocytosis among Melanesians. Vox Sang 1977; 32: 99-110.
33. Smythe JS, Spring FA, Gardner B, Parsons SF, Judson P, Anstee DJ. Monoclonal antibodies recognising epitopes on the extracellular face and intracellular N-terminus of the human erythrocyte anion transporter (Band 3) and their application to the analysis of Southeast Asian ovalocytes. Blood 1995; 85: 2929-2936.
34. 2 terminus. Am J Physiol 1993; 265: F813-F821.
35. Bruce LJ, Cope DL, Jones GK et al. Familial renal tubular acidosis is associated with mutations in the red cell anion exchanger (band 3: AE1) gene. J Clin Invest 1997; 100: 1693-1707.
36. Kay MMB. Cellular and molecular biology of senescent cell antigen. In: Garratty G, ed. Immunobiology of transfusion medicine. New York: Marcel Dekker, 1994: 173-198.
37. Oh SS, Chisti AH, Palek J, Liu S-C. Erythrocyte membrane alterations in Plasmodiumfalciparum malaria sequestration. Curr Opinion Hemat 1997; 4: 148-154.
38. Parsons SF, Jones J, Anstee DJ et al. A novel form of congenital dyserythropoietic anemia associated with deficiency of erythroid CD44 and a unique blood group phenotype [In(a-b-), Co(a-b-)]. Blood 1994; 83: 860-868.
39. King LS, Agre P. Pathophysiology of the aquaporin water channels. Annu Rev Physiol 1996; 58: 619-648.
40. Preston GM, Agre P. Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: member of an ancient channel family. Proc Natl Acad Sci USA 1991; 88: 11110-11114.
41. r 28.000 integral membrane protein from erythrocytes and renal tubules. J Biol Chem 1988; 263: 15634-15642.
42. Smith BL, Preston GM, Spring F, Anstee DJ, Agre P. Human red cell Aquaporin CHIP. I. Molecular characterization of ABH and Colton blood group antigens. J Clin Invest 1994; 94: 1043-1049.
43. Smith BL, Baumgarten R, Nielsen S, Raben D, Zeidel ML, Agre P. Concurrent expression of erythroid and renal aquaporin CHIP and appearance of water channel activity in perinatal rats. J Clin Invest 1993; 92: 2035-2041.
44. 2 permeability of Xenopus oocytes. Am J Physiol 1998; 274: C543-C548.
45. Preston GM, Smith BL, Zeidel ML, Moulds JJ, Agre P. Mutations in aquaporin-1 in phenotypically normal humans without functional CHIP water channels. Science 1994; 265: 1585-1587.
46. Agre P, Smith BL, Baumgarten R et al. Human red cell Aquaporin CHIP. II. Expression during normal fetal development and in a novel form of congentital dyserythropoietic anemia. J Clin Invest 1994; 94: 1050-1058.
47. Ma T, Yang B, Gillespie A, Carlson EJ, Epstein CJ, Verkman AS. Severly impaired urinary concentrating ability in transgenic mice lacking aquaporin-1 water channels. J Biol Chem 1998; 273: 4296-4299.
48. Wintour EM. Water channels and urea transporters. Clin Exp Pharmacol Physiol 1997; 24: 1-9.
49. Roudier N, Verbavatz J-M, Maurel C, Ripoche P, Tacnet F. Evidence for the presence of aquaporin-3 in human red blood cells. J Biol Chem 1998; 273: 8407-8412.
50. Yang B, Verkman AS. Urea tranporter UT3 functions as an efficient water channel. Direct evidence for a water/urea pathway. J Biol Chem 1998; 273: 9369-9372.
51. Olivès B, Merriman M, Bailly P et al. The molecular basis of the Kidd blood group polymorphism and its lack of association with type 1 diabetes susceptability. Hum Mol Genet 1997; 6: 1017-1020.
52. Olives B, Neau P, Bailly P et al. Cloning and functional expression of a urea transporter from human bone marrow cells. J Biol Chem 1994; 269: 31649-31652.
53. Olivès B, Mattei M-G, Huet M et al. Kidd blood group and urea transport function of human erythrocytes are carried by the same protein. J Biol Chem 1995; 270: 15607-15610.
54. Xu Y, Olivès B, Bailly P et al. Endothelial cells of the kidney vasa recta express the urea transporter HUT11. Kidney Int 1997; 51: 138-146.
55. Macey RI, Yousef LW. Osmotic stability of red cells in renal circulation required rapid urea transport. Am J Physiol 1988; 254: C669-C674.
56. Henry S, Woodfield G. Frequencies of the Jk(a-b-) phenotype in Polynesian ethnic groups. Transfusion 1995; 35: 277.
57. null individuals. J Biol Chem 1998; 273: 12973-12980.
58. Fröhlich O, Macey RI, Edwards-Moulds J, Gargus JJ, Gunn RB. Urea transport deficiency in Jk(a-b-) erythrocytes. Amer J Physiol 1991; 260: C778-C783.
59. Heaton DC, McLoughlin K. Jk(a-b-) red blood cells resist urea lysis. Transfusion 1982; 22: 70-71.
60. Sands JM, Gargus JJ, Fröhlich O, Gunn RB, Kokko JB. Urinary concentrating ability in patients with Jk(a-b-) blood type who lack carrier-mediated urea transport. J Amer Soc Nephrol 1992; 2: 1689-1696.
61. Olivès B, Martial S, Mattie M-G et al. Molecular characterization of a new kidney urea transporter in the human kidney. FEBS Lett 1996; 386: 156-160.
62. Avent ND, Ridgwell K, Tanner MJA, Anstee DJ. cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)-blood-group-antigen expression. Biochem J 1990; 271: 821-825.
63. Avent ND, Butcher SK, Liu W et al. Localization of the C termini of the Rh (Rhesus) polypeptides to the cytoplasmic face of the human erythrocyte membrane. J Biol Chem 1992; 267: 15134-15139.
64. Ridgwell K, Spurr NK, Laguda B, Macgeoch C, Avent ND, Tanner MJA. Isolation of cDNA clones for a 50 kDa glycoprotein of the human erythrocyte membrane associated with Rh (Rhesus) blood-group antigen expression. Biochem J 1992; 287: 223-228.
65. Cherif-Zahar B, Raynal V, Gane P et al. Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency. Nature Genet 1996; 12: 168-173.
66. Chérif-Zahar B, Raynal V, Le Van Kim C et al. Structure and expression of the RH locus in the Rh-deficiency syndrome. Blood 1993; 82: 656-662.
67. Chérif-Zahar B, Matassi G, Raynal V et al. Molecular defects of the RHCE gene in Rh-deficient individuals of the amorph type. Blood 1998; 92: 639-646.
68. null disease: the amorph type results from a novel double mutation in RhCe gene on D-negative background. Blood 1998; 92: 664-671.
69. Nash R, Shojania AM. Hematological aspect of Rh deficiency syndrome: a case report and a review of the literature. Amer J Hemat 1987; 24: 267-275.
70. null human erythrocytes have an abnormal membrane phospholipid organization. Biochem J 1984; 221: 931-934.
71. null red blood cells. Blood 1976; 48: 457-468.
72. Ballas SK, Clark MR, Mohandas N et al. Red cell membrane and cation deficiency in Rh null syndrome. Blood 1984; 63: 1046-1055.
73. Lindberg FP, Lublin DM, Telen MJ et al. Rh-related CD47 is the signal-transducer integrin-associated protein. J Biol Chem 1994; 269: 1567-1570.
74. Chérif-Zahar B, Bloy C, Le Van Kim C et al. Molecular cloning and protein structure of a human blood group Rh polypeptide. Proc Natl Acad Sci USA 1990; 87: 6243 6247.
75. Schroit AJ, Bloy C, Connor J, Cartron J-P. Involvement of Rh blood group polypeptides in the maintenance of aminophospholipid asymmetry. Biochemistry 1990; 29: 10303-10306.
76. null crythrocytes. Blood 1990; 76: 1021-1027.
77. + transporters. Trends Biochem Sci 1997; 22: 460-461.
78. Ho M, Chelly J, Carter N, Danek A, Crocker P, Monaco AP. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 1994; 77: 869 880.
79. Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Annu Rev Neurosci 1993; 16: 73-93.
80. Khamlichi S, Bailly P, Blanchard D, Goosens D, Cartron J-P, Bertrand O. Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients. Eur J Biochem 1995; 228: 931 934.
81. Russo D, Redman C, Lee S. Association of XK and Kell blood group proteins. J Biol Chem 1998; 273: 13950 13956.
82. Daniels GL, Weinauer F, Stone C et al. A combination of effects of rare genotypes at the XK and KEL blood group loci results in absence of Kell system antigens from the red blood cells. Blood 1996; 88: 4045-4050.
83. Marsh WL, Redman CM. Recent developments in the Kell blood group system. Transfusion Med Rev 1987; 1: 4 20.
84. Mueckler M, Caruso C, Baldwin SA et al. Sequence and structure of a human glucose transporter. Science 1985; 229: 941 945.
85. Griffiths M, Beaumont N, Yao SYM et al. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nature Med 1997; 3: 89 93.
86. Brugnara C. Erythrocyte membrane transport physiology. Curr Opinion Hemat 1997; 4: 122 127.
87. Chaudhuri A, Polyakova J, Zbrzezna V, Pogo AO. The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals. Blood 1995; 85: 615 621.
88. b alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood 1995; 85: 622-626.
89. Peiper SC, Wang Z, Neote K et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy-negativc individuals who lack the erythrocyte receptor. J Exp Med 1995; 181: 1311 1317.
90. Tournamille C, Le Van Kim C, Gane P, Cartron J-P, Colin Y. Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism. Hum Genet 1995; 95: 407-410.
91. b antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. BrJ Haemat 1995; 90: 823-829.
92. Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes crythroid gene expression in Duffy-negative individuals. Nature Genet 1995; 10: 224-228.
93. Darbonne WC, Rice GC, Mohler MA et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991; 88: 1362-1369.
94. Ncote K, Darbonne W, Ogez J, Horuk R, Schall TJ. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993; 268: 12247-12249.
95. Horuk R, Colby TJ, Darbonne WC, Schall TJ, Neote K. The human erythrocyte inflammatory peptide (chemokine) receptor, biochemical characterization, solubilization, and development of a binding assay for the soluble receptor. Biochemistry 1993; 32: 5733-5738.
96. Chaudhuri A, Polyakova J, Zbrzezna V, Wiliams K, Gulati S, Pogo AO. Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc Natl Acad Sci USA 1993; 90: 10793-10797.
97. Hadley TJ, Peiper SC. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 1997; 89: 3077-3091.
98. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ. Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem 1991; 60: 653-688.
99. Tournamille C, Le Van Kim C, Gane P et al. Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulphide bond is required for ligand binding. J Biol Chem 1997; 272: 16274-16280.
100. Hadley TJ, Lu Z, Wasniowska K et al. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the crythroid isoform, which is the Duffy blood group antigen. J Clin Invest 1994; 94: 985-991.
101. Chaudhuri A, Nielsen S, Elkjacr M-L, Zbrezna V, Fang F, Pogo AO. Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial an epithelial cells of nonerythroid organs. Blood 1997; 89: 701 712.
102. Horuk R, Martin AW, Wang Z et al. Expression of chemokinc receptors by subsets of neurons in the central nervous system. J Immunol 1997; 158: 2882 2890.
103. Mallinson G, Burgess G, Hook S, Murphy M, Poole J, Anstee DJ. A Caucasian individual with the Fy(a-b-) phenotype has a novel defect in the FY gene. Transfusion Med 1995; 5 supplement 1: 19 (abstract).
104. Pogo O, Chaudhuri A. Personal communication to Reid ME. Molecular basis for blood groups and function of carrier proteins. In: Silberstein LE, ed. Molecular and functional aspects of blood group antigens. Bethesda: American Association of Blood Banks, 1995: 111.
105. Williams AF, Barclay AN. The immunoglobulin superfamily domains for cell surface recognition. Ann Rev Immunol 1988; 6: 381-405.
106. Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merwe PA. The leucocyte antigen facts book. 2nd edn. London: Academic Press, 1997.
107. Mallinson G, Green CA, Okubo Y, Daniels GL. The molecular background of recessive Lu(a-b-) phenotype in a Japanese family. Transfusion Med 1997; 7 supplement 1: 18 (abstract).
108. Parsons SF, Mallinson G, Holmes CH et al. The Lutheran blood group glycoprotcin, another member of the immunoglobulin superfamily, is widely expressed in human tissues and is developmentally regulated in human liver. Proc Natl Acad Sci USA 1995; 92: 5496 5500.
109. Rahucl C, Le Van Kim C, Mattei MG, Cartron JP, Colin Y. A unique gene encodes spliceoforms of the B-cell adhesion molecule cell surface glycoprotein of epithelial cancer and of the Lutheran blood group glycoprotein. Blood 1996; 88: 1865 1872.
110. Udani M, Zen Q, Cottman M et al. Basal cell adhesion molecule/Lutheran protein. The receptor critical for sickle cell adhesion to laminin. J Clin Invest 1998; 101: 2550-2558.
111. Nemer WE, Gane P, Colin Y et al. The Lutheran blood , group glycoproteins, the erythroid receptors for laminin, are adhesion molecules. J Biol Chem 1998; 273: 16686-16693.
112. Southcott MJG, Parsons SF, Anstee DJ, Tanner MJA. Lutheran glycoprotein, a cell adhesion molecule that binds laminin with high affinity, is expressed on late erythrocyte precursors and appears after band 3. Blood 1997; 90 supplement 1; 175b (abstract).
113. Hermand P, Le Pennec PY, Rouger P, Cartron J-P, Bailly P. Characterization of the gene encoding the human LW blood group protein in LW: and LW phenotypes. Blood 1996; 87: 2962-2967.
114. Bailly P, Hermand P, Callebaut I et al. The LW blood group glycoprotein is homologous to intercellular adhesion molecules. Proc Natl Acad Sci USA 1994; 91: 5306-5310.
115. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
116. Bailly P, Tontti E, Hermand P, Cartron J-P, Gahmberg CG. The red cell LW blood group protein is an intercellular adhesion molecule which binds to CD11/CD18 leukocyte integrins. Eur J Immunol 1995; 25: 3316-3320.
117. Giles CM. The LW blood group: a review. Immunol Comm 1980; 9: 225-242.
118. a blood group antigen. Immunogenetics 1988; 27: 322-329.
119. a blood group antigen is a marker for the M6 leukocyte activation antigen, the human homolog of OX-47 antigen, basigin and neurothelin, an immunoglobulin superfamily molecule that is widely expressed in human cells and tissues. Eur J Immunol 1997; 27: 891-897.
120. Kasinrerk W, Fiebiger E, Stefanová I, Baumruker T, Knapp W, Stockinger H. Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule. J Immunol 1992; 149: 847-854.
121. Biswas C, Zhang Y, DeCastro R et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995; 55: 434-439.
122. Borland G, Ross JA, Guy K. Forms and functions of CD44. Immunology 1998; 93: 139-148.
123. Lesley J, Hyman R, Kincade PW. CD44 and its interactions with extracellular matrix. Adv Immunol 1993; 54: 271-335.
124. Miyake K, Underhill CB, Lesley J, Kincade PW. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990; 172: 69-75.
125. Oostendorp RAJ, Spitzer E, Brandi M, Eaves CJ, Dörmer P. Evidence for differences in the mechanisms by which antibodies against CD44 promote adhesion of erythroid and granulopoietic progenitors to marrow stromal cells. Br J Haemat 1998; 101: 436-445.
126. Telen MJ, Udani M, Washington MK, Levesque C, Lloyd E, Rao N. A blood group-related polymorphism of CD44 abolishes a hyaluronan-binding consensus sequence without preventing hyaluronan binding. J Biol Chem 1996; 271: 7147-7153.
127. Yang B, Yang BL, Savani RC, Turley EA. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J 1994; 13: 286-296.
128. Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 1993; 122: 257 264.
129. Telen MJ, Rao N, Udani M, Liao H-X, Haynes BF. Relationship of the AnWj blood group antigen to expression of CD44. Transfusion 1993; 33 supplement: 48S (abstract).
130. van Alphen L, Poole J, Overbeeke M. The Anton blood group antigen is the erythrocyte receptor for Haemophilus influenzas. FEMS Microbiol Letts 1986; 37: 69-71.
131. Uchikawa M, Tsuneyama H, Tadokoro K, Juji T, Yamada M, Maeda Y. An alloantibody to 12E7 antigen detected in 2 healthy donors. Transfusion 1995; 35 supplement: 23S (abstract).
132. Ellis NA, Ye T-Z, Patton S, German J, Goodfellow PN, Weller P. Cloning of PDBX, an MIC2-related gene that spans the pseudoautosomal boundary on Xp. Nature Genet 1994; 6: 394-399.
133. Bernard G, Breittmayer J-P, de Matteis M et al. Apoptosis of immature thymocytes mediated by E2/CD99. J Immunol 1997; 158: 2543-2550.
134. Bernard AF, Aubrit B, Raynal D, Pham D, Boumscll A. A T cell surface molecule different from CD2 is ivolved in spontaneous rosette formation with erythrocytes. J Immunol 1988; 140: 1802-1807.
135. . thymocytes. J Immunol 1995; 154: 26-32.
136. Hahn J-H, Kim MK, Choi EY et al. CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. J Immunol 1997; 159: 2250-2258.
137. Lublin DM, Mallinson G, Poole J et al. Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood 1994; 84: 1276-1282.
138. Daniels GL, Green CA, Mallinson G et al. Decay-accelerating factor (CD55) deficiency in Japanese. Transfusion Med 1998; 8: 141-147.
139. Wang L, Uchikawa M, Tsuneyama H, Tokunaga K, Tadokoro K, Juji T. Molecular cloning and characterization of decay-accelerating factor deficiency in Cromer blood group Inab phenotype. Blood 1998; 91: 680-684.
140. Lublin DM, Atkinson JP. Decay-accelerating factor: biochemistry, molecular biology, and function. Ann Rev Immunol 1989; 7: 35-58.
141. Coyne KE, Hall SE, Thompson ES et al. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol 1992; 149: 2906-2913.
142. Daniels GL, Green CA, Powell RM, Ward T. Hemagglutination-inhibition of Cromer blood group antibodies with soluble recombinant decay-accelerating factor. Transfusion 1998; 38: 332-336.
143. Hamann J, Vogel B, van Schijndel GMW, van Lier RAW. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J Exp Med 1996; 184: 1185-1189.
144. Lachmann PJ. The control of homologous lysis. Immunol Today 1991; 12: 312-315.
145. Rosse WF, Ware RE. The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood 1995; 86: 3277-3286.
146. Holguin MH, Martin CB, Bernshaw NJ, Parker CJ. Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor. J Immunol 1992; 148: 498-502.
147. Yuan FF, Bryant JA, Fletcher A. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells. Immunol Cell Biol 1995; 73: 66-72.
148. Yamashina M, Ueda E, Kinoshita T et al. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal noturnal hemoglobinuria. New Eng J Med 1990; 323: 1184-1189.
149. Motoyama N, Okada N, Yamashina M, Okada H. Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene. Eur J Immunol 1992; 22: 2669-2673.
150. Wiesner J, Jomaa H, Wilhelm M, et al. Host cell factor CD59 restricts complement lysis of Plamodium falciparum-infected erythrocytes. Eur J Immunol 1997; 27: 2708-2713.
151. Schönermark S, Rauterberg EW, Shin ML, Löke S, Roelcke D, Hänsch GM. Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor. J Immunol 1986; 136: 1772-1776.
152. Mänsch GM, Schönermark S, Roelcke D. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9. J Clin Invest 1987; 80: 7-12.
153. Ahearn JM Fearon DT. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv Immunol 1989; 46: 183-219.
154. Moulds JM, Moulds JJ, Brown M, Atkinson JP. Antiglobulin testing for CR1-related (Knops/McCoy/Swain-Langley/York) blood group antigens: negative and weak reactions are caused by variable expression of CR1. Vox Sang 1992; 62: 230-235.
155. Reinagel ML, Gezen M, Ferguson PJ, Kuhn S, Martin EN, Taylor RP. The primate erythrocyte complement receptor (CR1) as a privileged site: binding of immunoglobulin G to erythrocyte CR1 does not target erythrocytes for phagocytosis. Blood 1997; 89: 1068-1077.
156. Rao N, Ferguson DJ, Lee S-F, Telen MJ. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol 1991; 146: 3502-3507.
157. Moulds JM, Nickells MW, Moulds JJ, Brown MC, Atkinson JP. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-Langley, and York blood group antisera. J Exp Med 1991; 173: 1159-1163.
158. Moulds JM. Association of blood group antigens with immunologically important proteins. In: Garratty G, ed. Immunobiology of transfusion medicine. New York: Dekker, 1994: 273-297.
159. Rowe JA, Moulds JM, Newbold CI, Miller LH. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 1997; 388: 292-295.
160. Bartels CF, Zelinski T, Lockridge O. Mutation at codon 322 in human acetylcholinesterasc (ACHE) gene accounts for YT blood group polymorphism. Amer J Hum Genet 1993; 52: 928-936.
161. Taylor P. The cholinesterases. J Biol Chem 1991; 266: 4025-4028.
162. Spring FA, Gardner B, Anstee DJ. Evidence that the antigens of the Yt blood group system are located on human erythrocyte acetylcholinesterase. Blood 1992; 80: 2136-2141.
163. Turner AJ, Tanzawa K. Mamallian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J 1997; 11: 355-364.
164. Lee S. Molecular basis of Kell blood group phenotypes. Vox Sang 1997; 73: 1-11 and Vox Sang 1998; 74: 58.
165. Lee S. Molecular basis of Kell blood group phenotypes. Vox Sang 1997; 73: 1-11 and Vox Sang 1998; 74: 58.
166. Belhacène N, Maulon L, Guérin S et al. Differential expression of the Kell blood group and CD10 antigens: two related membrane metallopeptidases during differentiation of K562 cells by phorbol ester and hemin. FASEB J 1998; 12: 531-539.
167. Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IAG. Inhibition of crythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. New Engl J Med 1998; 338: 798-803.
168. Jentoft N. Why are proteins O-glycosylated? Trends Biochem Sci 1990; 15: 291-294.
169. Chasis JA, Mohandas N. The role of red cell glycophorins in regulating membrane function. In: Agre PC, Cartron J-P, eds. Protein blood group antigens of the human red cell structure, function and clinical significance. Baltimore: Johns Hopkins, 1992: 152-169.
170. Marchesi VT. Functional proteins of the human red blood cell membrane. Semin Hemat 1979; 16: 3-20.
171. Blumenfeld OO, Huang C-H. Molecular genetics of the glycophorin gene family, the antigens for MNSs blood groups: multiple gene rearrangements and modulation of splice site usage result in extensive diversification. Hum Mutation 1995; 6: 199-209.
172. Paulitschke M, Nash GB, Anstee DJ, Tanner MJA, Gratzer WB. Perturbation of red blood cell membrane rigidity by extracellular ligands. Blood 1995; 86: 342-348.
173. Tomita A, Radike EL, Parker CJ. Isolation of erythrocyte membrane inhibitor of reactive lysis type II. Identification as glycophorin A. J Immunol 1993; 151: 3308-3323.
174. El Ouagari K, Teissié J, Benoist H. Glycophorin A protects K562 cells from natural killer cell attack. Role of oligosaccharides. J Biol Chem 1995; 270: 26970-26975.
175. Le Van Kim C, Piller V, Cartron J-P, Colin Y. Glycophorins C and D are generated by the use of alternative translation initiation sites. Blood 1996; 88: 2364-2365.
176. Marfatia SM, Morais-Chabral JH, Kim AC, Byron O, Chisti AH. The PDZ domain of human erythrocyte p55 mediates its binding to the cytoplasmic carboxyl terminus of glycophorin C. Analysis of the binding interface by in vitro mutagenesis. J Biol Chem 1997; 272: 24191-24197.
177. Workman RF, Low PS. Biochemical analysis of potential sites for protein 4.1-mediated anchoring of the spectrin-actin skeleton to the erythrocyte membrane. J Biol Chem 1998; 273:6171-6176.
178. Daniels GL, Shaw M-A, Judson PA et al. A family demonstrating inheritance of the Leach phenotype: a Gerbich-negative phenotype associated with elliptocytosis. Vox Sang 1986; 50: 117-121.
179. Nash GB, Parmar J, Reid ME. Effects of deficiencies of glycophorins C and D on the physical properties of the red cell. Br J Haemat 1990; 76: 282-287.
180. Alloisio N, Venezia ND, Rana A, et al. Evidence that red blood cell protein p55 may participate in the skeleton-membrane linkage that involves protein 4.1 and glycophorin C. Blood 1993; 82: 1323-1327.
181. Hadley TJ, McGinniss MH, Klotz FW, Miller LH. Blood group antigens and invasion of erythrocytes by malaria parasites. In: Garratty G, ed. Red cell antigens and antibodies. Arlington, VA: American Association of Blood Banks, 1986; 17-33.
182. Chisti AH, Palek J, Fisher D, Maalouf GJ, Liu S-C. Reduced invasion and growth of Plasmodiumfalciparum into elliptocytic red blood cells with a combined deficiency of protein 4.1, glycophorin C, and p55. Blood 1996; 87: 3462-3469.
183. DeLuca GM, Donnell ME, Carrigan DJ, Blackall P. Plasmodiumfalciparum merozoite adhesion is mediated by sialic acid. Biochem Biophys Res Comm 1996; 225: 726-732.
184. Sim BKL, Chitnis CE, Wasniowska K, Hadley TJ, Miller LH. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 1994; 264: 1941-1944.
185. Kosciclak J. A hypothesis on the biological role of ABH, Lewis and P blood group structures in glycosphingolipids and glycoproteins. Gycoconjugate J 1986; 3: 95-108.
186. Oriol R. ABO, Hh, Lewis, and secretion. Serology, genetics, and tissue distribution. In: Cartron J-P, Rouger P, eds. Blood cell biochemistry. Vol. 6. Molecular basis of human blood group antigens. New York: Plenum, 1995: 36-73.
187. Greenwell P. Blood group antigens: molecules seeking a function? Gycoconjugate J 1997; 14: 159-173.
188. Moulds JM, Nowicki S, Moulds JJ, Nowicki BJ. Human blood groups: incidental receptors for viruses and bacteria. Transfusion 1996; 36: 362-374.